
    
      -  During the first week of treatment, participants will receive 2 doses of Alefacept
           intravenously (Day 1 and Day 4). During weeks 2-12, Alefacept will be given
           subcutaneously once weekly.

        -  On weeks 1, 2 and every other week through Week 12 of study treatment, participants will
           have a physical exam, blood tests, and be asked general health and specific questions
           about any problems they may be having.

        -  Every other week, participants will be asked to complete a questionnaire about their
           physical symptoms, activity level and emotional well being.
    
  